Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

News Daily News

Top Endovascular News of 2024

L.A. McKeown

December 28, 2024

News Conference News VIVA 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

L.A. McKeown

November 05, 2024

News Conference News TCT 2024

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

L.A. McKeown

October 29, 2024

Presentation TCT 2024

Esprit™ BTK System Device & Data Overview, Real-World Case Discussion and Patient Selection

Presenter: Ethan Korngold

October 28, 2024

Presentation TCT 2024

BTK Drug Coated Balloons: 1 Year After LIFE BTK – We Need Them More Than Ever

Presenter: Peter Schneider

October 28, 2024

Presentation TCT 2024

BTK and BTA: How is Promise II and DVA Making an impact?

Presenter: Anahita Dua

October 28, 2024

Presentation TCT 2024

BTK Scaffolds: 1 Year After LIFE BTK – The Landscape is Shifting

Presenter: Brian DeRubertis

October 28, 2024

Presentation TCT 2024

Cost Effectiveness of Drug-Eluting Resorbable Scaffold Versus Angioplasty for Infrapopliteal Artery Disease From the LIFE-BTK Trial

Presenter: Sahil Parikh

October 28, 2024

Presentation TCT 2024

TCT 26: Pharmacokinetic Profile of Everolimus Eluted From the Esprit BTK Scaffold: Data From the LIFE-BTK Pharmacokinetics Sub-Study

Presenter: Richard Pin

October 27, 2024

News Daily News

FDA Approves Bioresorbable Scaffold for BTK Lesions

Michael O'Riordan

April 29, 2024

News Conference News ISET 2024

Tack Works Well in Dissection Repair of Complex Lesions: TOBA II BTK

Caitlin E. Cox

January 25, 2024

News Daily News

New Scientific Statement Focuses on Below-the-Knee Technical Challenges

L.A. McKeown

January 19, 2024

Advertisement

Top Endovascular News of 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

Esprit™ BTK System Device & Data Overview, Real-World Case Discussion and Patient Selection

BTK Drug Coated Balloons: 1 Year After LIFE BTK – We Need Them More Than Ever

BTK and BTA: How is Promise II and DVA Making an impact?

BTK Scaffolds: 1 Year After LIFE BTK – The Landscape is Shifting

Cost Effectiveness of Drug-Eluting Resorbable Scaffold Versus Angioplasty for Infrapopliteal Artery Disease From the LIFE-BTK Trial

TCT 26: Pharmacokinetic Profile of Everolimus Eluted From the Esprit BTK Scaffold: Data From the LIFE-BTK Pharmacokinetics Sub-Study

FDA Approves Bioresorbable Scaffold for BTK Lesions

Tack Works Well in Dissection Repair of Complex Lesions: TOBA II BTK

New Scientific Statement Focuses on Below-the-Knee Technical Challenges

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content